State Ledger
Company profile

GENELUX Corp CIK 1231457

Ticker
GNLX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Westlake Village, CA 91361
Fiscal year end
2025 (FY)
Market Data
Close
$2.55
Change
-$0.01
Change %
-0.39%
Volume
4,748

GNLX · trading date Oct 12, 2026 · previous close $2.56 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$8.0K
Net income
-$32.15M
Total assets
$19.03M
Total liabilities
$7.48M
Stockholders' equity
$11.54M
Cash & equivalents
$5.33M
Operating income
-$33.21M
Operating cash flow
-$25.27M
Capital expenditures
$1.10M

Fiscal year 2025, via 10-K filed 2026-03-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-415,175.0%
Net margin
-401,812.5%
Free cash flow
-$26.37M
Free cash flow margin
-329,575.0%
Liabilities / assets
39.3%
Equity / assets
60.7%
CapEx / revenue
13,725.0%
Operating cash flow / net income
0.79×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $8.0K -$32.15M $19.03M $7.48M $11.54M
2024 $8.0K -$29.87M $34.72M $8.44M $26.27M
2023 $170.0K -$28.30M $27.89M $8.42M $19.47M
2022 $11.07M -$5.21M $5.53M $41.31M -$35.78M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-02
Financials filed via
Form 10-K
filed 2026-03-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Westlake Village, CA 91361
2625 TOWNSGATE ROAD, SUITE 230
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies